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ABSTRACT  
Objective: The objective of this study was to isolate and characterize the bioactive principles from the aqueous ethanolic extract of flower buds of 
Eugenia caryophyllus. 
Methods: The isolation was done using column chromatography using gradient elution with different mobile phases. The isolated compound was 
subjected to spectral analysis. Structure elucidation was carried out on basis of spectral analysis. 
Results: The infra-red spectra showed specific absorption bands for flavanoids viz. 1245.86 to 1111.01 cm-1 for HCO stretch of ether; 1330 to 1050 
cm-1 for CO stretch of lactone. In addition IR spectrum showed specific absorption bands for flavanoids viz. 3432.57cm-1 for OH stretch for alcohol 
and phenol. Mass spectra showed pseudomolecular ion (M+ion) peak at m/z 464 which corresponds to molecular formula C21H20O12
Conclusion: From the spectral characteristics, the isolated compound from the extract was confirmed to be Gossypetin 7-O rhamnopyranoside 
(Rhodiolgin). 
. 
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INTRODUCTION 
Natural products like plant extracts, either as pure compounds or as 
standardized extracts provide unlimited opportunities for new drug 
discoveries due to unmatched availability of chemical diversity [1]. 
According to World Health Organization (WHO), more than 80% of 
the world's population relies on traditional medicine for their 
primary healthcare needs [2]. Plants used for traditional medicine 
contain a wide range of substances that can be used to treat chronic 
as well as infectious diseases. Due to various adverse effects of the 
available synthetic drugs, men have turned to ethnopharmacognosy. 
Since plant extracts usually occur as a combination of various 
bioactive compounds or phytochemicals with different polarities, 
isolating the pure compound becomes very necessary and it holds a 
big challenge. Column chromatography technique is the most widely 
used for separation, isolation & purification of chemical constituents 
from natural drugs. 
Eugenia caryophyllus is a small ever-green tree that belongs to the 
botanical family Myrtaceae (subfamily: Myrtoideae and tribe: 
Syzgieae) and scientifically known as Syzygium aromaticum (L.) 
Merr. & L.M. Perry. Dried flower buds of Eugenia caryophyllus are 
used as a spice. The essential oil obtained from the buds of Eugenia 
caryophyyllus L. is widely known for its medicinal properties. 
Chemical analysis has identified the major constituents as eugenol, 
eugenyl acetate, beta-caryophyllene, 2-heptanone [3]. Its oil has 
anti-oxidant properties and in dentistry used as a topical application 
to relieve pain and to promote healing and also finds use in the 
fragrance and flavouring industries. The essential oil has shown to 
have anti-microbial activity [4,5] and anti-fungal properties against 
dermatophytes [6,7]. In addition, it is found to have antimutagenic 
[8], anti-inflammatory [9], antiulcerogenic [10,11], antithrombotic 
[12] and antiparasitic [13] and an anti-convulsant [14] activity. The 
anti-oxidant effect of eugenol has been reported on carbon 
tetrachloride induced erythrocyte damage in rats [15]. 
Pharmacological studies with Eugenia caryophyllus extract have also 
demonstrated anti-stress activity [16], analgesic activities [17,18] 
and found to be more potent than aspirin in inhibiting platelet 
aggregation [19]. Due to such wide therapeutic activities, it was 
decided to investigate bioactive compounds from aqueous ethanolic 
extract of Eugenia carophyllus flower buds. 
MATERIALS AND METHODS 
Plant materials 
The flower buds of Eugenia caryophyllus was collected from an 
authorized vendor Global Herbs and authenticated by Professor 
Mohammed Ali, Department of Pharmacognosy, Faculty of 
Pharmacy, Jamia Hamdard, New Delhi. A voucher specimen coded 
PRL/JH/11/01 was deposited in the Jamia Hamdard.  
Extraction procedure 
The flower buds of Eugenia caryophyllus were dried at room 
temperature and reduced to coarse powder. The powdered material 
was subjected to qualitative tests [20,21] for the identification of 
various phytoconstituents like alkaloids, flavanoids, phenols, 
phytosterols etc. Then the powder was subjected to cold maceration 
with 70% ethanol for 7 days at room temperature. After 7 days, it 
was filtered and the filtrate was concentrated on water bath to 
obtain a dark brownish residue.  
Isolation 
A column tube 1ft X 2.5 cm was taken and dried. The lower end of 
the column was plugged with absorbent cotton. The column was 
clamped and fitted in vertical position on a stand. The column was 
then half filled with n-hexane & silica gel slurry poured in small 
portions and allowed to settle gently till a necessary length of the 
column was obtained. The extract which was adsorbed in silica gel, 
then poured onto the bed of silica, covered it again with a layer of 
cotton wool and more amount of solvent was poured over it. The 
column was then run by gradient elution technique. 70% ethanolic 
extract was subjected to column chromatography using different 
solvent systems (100% benzene, 75%benzene: 25% chloroform, 
50% benzene: 50% chloroform, 25% benzene: 75% chloroform, 
100% chloroform, 75% chloroform: 25% acetone, 50% chloroform: 
50% acetone, 25% chloroform: 75% acetone, 100% acetone, 60% 
acetone: 40% ethyl acetate, 40% acetone: 60% ethyl acetate, 100% 
ethyl acetate, 80% ethyl acetate: 20% methanol, 60% ethyl acetate: 
40% methanol, 40% ethyl acetate: 60% methanol, 20% ethyl 
acetate: 80% methanol, 100% methanol, 80% methanol: 20% water, 
60% methanol: 40% water, 40% methanol: 60% water, 20% 
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methanol: 80% water, ethylacetate-methanol-water (10:1.35:1) and 
ethyl acetate: formic acid: glacial acetic acid: water (10:1.1:1.1:2.6) 
in a glass column.  
All the fractions collected in the conical flasks were marked. The 
marked fractions were subjected to thin layer chromatography to 
check the homogeneity of various fractions.  
Elution of drug in column using methanol: water (0.4:0.6) (fraction 
No. 20) designated as F20 yielded darkish orange coloured residue 
which was subjected to characterization. 
Physiochemical characterization 
One pure bioactive was isolated and the isolated pure fraction was 
tentatively identified using qualitative chemical analysis. Further 
identification & characterization was done using I.R, NMR & Mass 
spectroscopy. Infrared (I.R) Spectra analysis was recorded on FT-IR 
6700 Thermoscientific (Mcleods) spectrophotometer.  
The isolated test compound was subjected to IR using 
KBr/chloroform for the study of absorption of infra-red radiation 
with its corresponding functional groups clearly [22]. The 1H-NMR & 
13
The scan began from 50m/z and end at 1500m/z in low tune 
method. In wide tune method, scan began from 50m/z and end at 
3000m/z. 
C-NMR were recorded at room temperature using Bruker Avance 
III 500 NMR spectrophotometer and the solvent used was DMSO. 
The chemical shifts were given in δ (ppm) value relative to TMS as 
internal standard. The mass spectral analysis was performed on 
micro TOF QII. Electrospray ionization was used as a source.  
RESULTS AND DISCUSSION 
The IR spectra of the isolated compound is shown in Fig.1. The 1H 
NMR spectra is shown in Fig. 2. 13C NMR spectra of the isolated 
compound are shown at δ<200 ppm, δ<180 ppm, δ<65 ppm and 
δ<63 ppm respectively in Fig.3-6. The mass spectra of the isolated 
compound are expressed in Fig.7 (ranging from 370-505 m/z ratio) 
and in Fig. 8 ranging from 320-500m/z ratio. The interpretation of 
all the spectras are given in Tables 1 to 4. An IR spectra shows an 
absorption peak at 2864.02 cm-1 which indicates an ether linkage in 
the compound which is further confirmed by its 1H NMR & 13C NMR 
with singlet at δ 4.106 ppm and δ 153.16 ppm respectively. Presence 
of the alcohol/ phenol is confirmed by the presence of absorption 
peak at 3432.57 cm-1 in the IR spectra and a narrow long singlet is 
observed at δ 3.095 ppm in 1H NMR. Further the presence of lactone 
in sugar, ketonic linkage, aromatic hydrocarbon and cycloalkane are 
confirmed and the values are given in the Tables 1, 2 and 3. Mass 
spectral analysis also indicates the evidence of alcohol, gossypetin 
methyl ester, terminal vinyl, some ethyl esters and butyl esters with 
the corresponding M+ ion peak at m/z 464 (Table:4). All these 
spectral data, suggests that the isolated compound eluted from the 
column chromatography was found to be Gossypetin 7-O-





Fig. 1: IR spectra of the isolated lead compound 
 
Table 1: Interpretation of IR spectra of isolated compound 
S. No Wave Number cm Characterstic functional group -1 Compound type/Expected group 
1. 3432.57 -O-H st Alcohols/Phenols 
2. 2864.02 H-C(-O-)st. Ether 
3. 1640.80 C=Ost. Ketone 
4. 1450.00 Ar-C-C st Benzene ring 
5. 1245.86 C-O st. Lactone in sugar 
6. 1017.71 C-O(H)st Alcohols/Phenols 
7. 604.81 =C-H δ bend Alkene 
 
Table 2: Interpretation of 1
S. No. 
H-NMR spectra of the isolated lead 
Assignment Range (delta) Nature of peak Comments/significance 
1. CH2 4.106 ppm -O Broad elongated singlet Presence of Ether 
2. -CH-OH 3.095 ppm Narrow long singlet Presence of alcohol & phenol of sugar 
3. CH-(C) 2.859 Narrow low singlet Presence of aromatic hydrocarbon 
4. CH2 1.844 -(C) Narrow singlet Presence of aromatic hydrocarbon 
5. CH2 1.837 (scale) -(C=C)  Presence of cycloalkane 
6. CH2 1.044 Triplet Presence of alkanes 
Ghai et al. 










C- NMR spectra of the isolated lead compound (δ ˂200 ppm) 
 
Fig. 4: 13C- NMR spectra of the isolated lead compound (δ˂180 ppm) 
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C- NMR spectra of the isolated lead compound (δ˂63 ppm) 
Table 3: Interpretation of 13
S. No. 
C NMR spectra of the isolated lead compound 
Assignment Range observed  Nature of peak Comments/Expected group  
1. COOR group 170.961 Singlet Carboxylic ester and lactone (sugar) 
2. Ar-C-X      or 
Ar-C-OH   or 
Ar-C-O 
 
153.16 Singlet Heteroaromatic compound 
Alcohol and Phenol 
Ether  
3. 
 Methylene Carbon 















5. CH-Carbon 20.506 Singlet alkane or cycloalkane 
6. CH2 carbon 13.970 Singlet methylene Carbon 
7 d6 39.319 -DMSO Triplet Solvent  
Ghai et al. 




Fig. 7: Mass spectra of the isolated lead compound (370-505 m/z ratio) 
 
 
Fig. 8: Mass spectra of the isolated lead compound (320-500m/z ratio) 
 
Table 4: Mass spectral interpretation of the isolated lead compound 
S. 
No. 
Mass Ion Product ion & composition of neutral particle 
lost/Adduct peak formation 
Sub-structure or 
compound type 
m/z ratio of the compound 
fragmented peak 
1. 23 Na [M+23]+ Gossypetin methyl ester  + 
In presence of Na+ 
487 

























) Esters, acid 
377 




From the interpretation of all the spectras, the novel compound was 
elucidated to have chemical formula C21H20O12
 
Fig. 9: Structure of Gossypetin 7-O-Rhamnopyranoside 
(Rhodiolgin) 
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